Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies

Auteurs

M. Illiano, M. Colinard, S. Taque, B. Mallon, C. Larue, V. Laithier, C. Vérité-Goulard, H. Sudour-Bonnange, C. Faure-Conter, C. Coze, I. Aerts, C. Dumesnil De Maricourt, C. Paillard, S. Branchereau, L. Brugières, B. Fresneau